NCT05531708 2023-03-01
Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors
Shanghai Pudong Hospital
Phase 1 Withdrawn
Clinical Trials
1 trialsMesothelin-positive Advanced Refractory Solid Tumors × Cyclophosphamide × Other solid neoplasm × Clear all